Clinical Trials List
2024-01-01 - 2033-12-31
Phase III
Recruiting7
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 王樹吉 Division of Urology
- JU-CHUAN HU Division of Urology
- Cheng-Che Chen Division of Urology
- 裘坤元 Division of Urology
- Jian-Ri Li Division of Urology
- 張家程 Division of Urology
- 蔡世傳 Division of Nuclear Medicine
- Cheng-Kuang Yang Division of Urology
- 林雁婷 Division of Radiology
- 張瓈文 Division of Urology
- 楊哲瑞 Division of Urology
- 賴谷順 Division of Urology
- Shian-Shiang Wang Division of Urology
- 洪晟鈞 Division of Urology
- 梅承恩 Division of Urology
- 楊涵中 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Chieh Wang Division of Radiology
- 余家政 Division of Urology
- 郭威廷 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chien-Hsin Ting Division of Nuclear Medicine
- Yen-Hwa Chang Division of Urology
- Tzu-Hao Huang Division of Urology
- 蔡承翰 Division of Urology
- Chih-Chieh Lin Division of Urology
- Tzu-Hsiang Hsu Division of Urology
- William Huang Division of Urology
- Jiun-I Lai Division of Hematology & Oncology
- Liang-Yu Lin Division of Endocrinology
- 陳威任 Division of Urology
- I-Shen Huang Division of Urology
- Jia-An Hong Division of Radiology
- 彭昱璟 Division of Others
- Yi-Hsiu Huang Division of Urology
- Tzu-chun Wei Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hong-Cheng Gan Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Feng-Yuan Liu Division of Nuclear Medicine
- 余紹銘 Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- 吳俊德 Division of Hematology & Oncology
- 張鈞弼 Division of Radiology
- 黃文冠 Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Chao-Hsiang Chang Division of Urology
- 陳冠亨 Division of Urology
- Ching-Chan Lin Division of Hematology & Oncology
- Han Chang Division of General Surgery
- 蔡禮賢 Division of Urology
- Po-Fan Hsieh Division of Urology
- 鄭富銘 Division of Hematology & Oncology
- 謝德鈞 Division of Nuclear Medicine
- Yu-De Wang Division of Urology
- Wei-Ching Lin Division of Radiology
- Yi-Huei Chang Division of Urology
- Chi-Rei Yang Division of Urology
- Po-Jen Hsiao Division of Urology
- Hsi-Chin Wu Division of Urology
- 邱鴻傑 Division of Urology
- Chi-Shun Lien Division of Urology
- Su-Peng Yeh Division of Hematology & Oncology
- 賴俊佑 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
34 participants
-
Global
1314 participants
